COMPASS Pathways Total Long Term Liabilities 2019-2024 | CMPS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

COMPASS Pathways total long term liabilities from 2019 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

COMPASS Pathways total long term liabilities from 2019 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$92.8B
Cencora (COR)	$49.5B
DiDi Global (DIDIY)	$22.6B
Natera (NTRA)	$22.2B
ICON (ICLR)	$16.3B
Revvity (RVTY)	$15B
Avantor (AVTR)	$14.6B
BioMerieux (BMXMF)	$14.2B
Viatris (VTRS)	$13.5B
CochLear (CHEOY)	$12.9B
Solventum (SOLV)	$12.9B
Doximity (DOCS)	$10.8B
Medpace Holdings (MEDP)	$10.7B
EUROFINS SCIENT (ERFSF)	$10.1B
HealthEquity (HQY)	$9.4B
Sonic Healthcare (SKHHY)	$8.7B
Charles River Laboratories (CRL)	$8.3B
Bausch + Lomb (BLCO)	$6.3B
Amplifon S.p.A (AMFPF)	$6.1B
BrightSpring Health Services (BTSG)	$4.1B
Organon (OGN)	$4.1B
Sotera Health (SHC)	$3.9B
Surgery Partners (SGRY)	$3.3B
Concentras Parent (CON)	$3B
Alignment Healthcare (ALHC)	$2.9B
Premier (PINC)	$2.2B
Ardent Health Partners (ARDT)	$2.1B
PACS (PACS)	$2.1B
GeneDx Holdings (WGS)	$2.1B
Progyny (PGNY)	$2B